Kips Bay Medical, Inc. KIPS along with Manny Villafa, its
Founder, Chairman and CEO, announced today that its U.S. feasibility trial
(eMESH I) of the eSVS Mesh has commenced in Bern, Switzerland and
anticipates first implants and enrollments under this study to begin the
week of September 2, 2012. The objective of the eMESH I study remains the
demonstration of initial safety and performance of the Kips Bay Medical eSVS
Mesh sufficient to allow the FDA to approve an IDE for a pivotal study.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in